Onderneming Armata Pharmaceuticals, Inc.
Aandelen
ARMP
US04216R1023
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,76 USD | +9,06% | +3,56% | -14,81% |
Vakgebied
Aantal werknemers: 66
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pathogen-specific Bacteriophage Therapeutics
100,0
%
| 6 | 100,0 % | 5 | 100,0 % | -17,77% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States and Australia
100,0
%
| 6 | 100,0 % | 5 | 100,0 % | -17,77% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Deborah Birx
CEO | Chief Executive Officer | 68 | 11-07-23 |
Mina Pastagia
CTO | Chief Tech/Sci/R&D Officer | - | 26-10-20 |
Bryan Kadotani
PRN | Corporate Officer/Principal | - | - |
Richard Rychlik
AUD | Comptroller/Controller/Auditor | 68 | 05-09-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 64 | 12-02-20 | |
Joseph Patti
BRD | Director/Board Member | 60 | 09-05-19 |
Jules Haimovitz
BRD | Director/Board Member | 73 | 01-04-21 |
Odysseas Kostas
BRD | Director/Board Member | 49 | 12-02-20 |
Robin Kramer
CHM | Chairman | 58 | 08-12-20 |
Todd Peterson
BRD | Director/Board Member | 66 | 10-10-19 |
Deborah Birx
CEO | Chief Executive Officer | 68 | 11-07-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 36 148 539 | 10 719 501 ( 29,65 %) | 0 | 29,65 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-14,81% | 99,77 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |
- Beurs
- Aandelen
- Koers ARMP
- Onderneming Armata Pharmaceuticals, Inc.